The in-depth, constantly-changing birds-eye view of disease that computational models provide is an essential next step in linking our ever-expanding clinical knowledge and data with drug development.
The post From Trial-and-Error to Targeted Success: How Computational Disease Models Can Help Patients and Pharma Companies appeared first on MedCity News.
